COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02663895
Recruitment Status : Completed
First Posted : January 26, 2016
Last Update Posted : June 16, 2020
United Therapeutics
Information provided by (Responsible Party):
Lorinda S Chung, Stanford University

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2020
Actual Study Completion Date : May 2020